CLDN4 and metastatic carcinoma: In another study by Bernardi et al., Claudin-4 expression was assessed in 49 MPM on cytology with 43 matched biopsies, 49 normal/reactive mesothelial proliferations, and 49 pleural metastatic carcinomas from different primaries with 21 matched pleural biopsies.